Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 1Granules India Limited
02 1BDR Lifesciences Private Limited
03 1Cambrex Charles City, Inc
04 1Chongqing Biocare Pharmaceutical Ltd.
05 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
06 1Formosa Laboratories, Inc.
07 1Hetero Labs Limited
08 1MSN Laboratories Private Limited
09 1Natco Pharma Limited
10 1SciAnda(Changshu) Pharmaceuticals, Ltd.
11 1ThermoFisher Scientific Cork
01 1LAPATINIB DITOSYLATE
02 6Lapatinib Ditosylate
03 1Lapatinib Ditosylate Anhydrous
04 2Lapatinib Ditosylate Monohydrate
05 1lapatinib
01 5India
02 1Italy
03 2Taiwan
04 2U.S.A
05 1Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-980
Start Marketing Date : 2023-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-4480
Start Marketing Date : 2014-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0095
Start Marketing Date : 2010-12-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66499-0046
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0072
Start Marketing Date : 2007-03-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0110
Start Marketing Date : 2021-02-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7421
Start Marketing Date : 2021-05-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54245-7005
Start Marketing Date : 2015-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61187-009
Start Marketing Date : 2014-09-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 33656-0014
Start Marketing Date : 2020-04-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
51
PharmaCompass offers a list of Lapatinib Ditosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lapatinib Ditosylate manufacturer or Lapatinib Ditosylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lapatinib Ditosylate manufacturer or Lapatinib Ditosylate supplier.
PharmaCompass also assists you with knowing the Lapatinib Ditosylate API Price utilized in the formulation of products. Lapatinib Ditosylate API Price is not always fixed or binding as the Lapatinib Ditosylate Price is obtained through a variety of data sources. The Lapatinib Ditosylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GW282974X manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GW282974X, including repackagers and relabelers. The FDA regulates GW282974X manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GW282974X API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of GW282974X manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A GW282974X supplier is an individual or a company that provides GW282974X active pharmaceutical ingredient (API) or GW282974X finished formulations upon request. The GW282974X suppliers may include GW282974X API manufacturers, exporters, distributors and traders.
click here to find a list of GW282974X suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing GW282974X as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for GW282974X API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture GW282974X as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain GW282974X and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a GW282974X NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of GW282974X suppliers with NDC on PharmaCompass.
We have 10 companies offering GW282974X
Get in contact with the supplier of your choice:
